Dicer Expression in Breast Cancer
Author Information
Author(s): Hinkal G W, Grelier G, Puisieux A, Moyret-Lalle C
Primary Institution: Centre Léon Bérard
Hypothesis
Is there a competition between different miRNAs in binding their targets in Dicer regulation?
Conclusion
Dicer downregulation is associated with epithelial-mesenchymal transition (EMT) in breast cancer.
Supporting Evidence
- Dicer expression was significantly decreased in breast cancer cells with mesenchymal phenotypes.
- Lower Dicer levels were associated with lower metastasis-free survival in breast cancer patients.
- Different Dicer mRNA variants were identified, correlating with breast cancer staging subtypes.
Takeaway
This study looks at how a protein called Dicer, which helps make small RNA molecules, is affected in breast cancer cells. When Dicer levels go down, it can lead to changes in how the cancer cells behave.
Methodology
Dicer expression was assessed using RT-qPCR and western blotting in breast cancer cell lines and patient cohorts.
Limitations
The physiological relevance of the findings remains to be clarified.
Participant Demographics
Breast cancer cell lines and human cohort data were used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website